Hospital
Shanghai First Maternity and Infant Hospital上海市第一妇婴保健院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Published research 20 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 4 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Administrative grade
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| Grade as published Tier 3, class A specialised hospital (re-accredited) 三级甲等专科医院（复评） | Tier 3, class A | 2020-12-24 | An administrative designation, not a ranking; the date is the list's own publication date, not the year the grade was awarded | The source of this record, at the foot of this page |
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 上海市第一妇婴保健院
- English name
- Shanghai First Maternity and Infant Hospital
- Grade
- Tier 3, class A specialised hospital (re-accredited) 三级甲等专科医院（复评）
- Grade list as published
- 2020-12-24
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- CBX8 suppresses autophagy-dependent senescence in colorectal cancer by modulating the mTOR signaling pathway. International journal of biological sciences, 2026
- EGFR-dependent delivery of phosphorylated IGFBP3 by cancer stem cells drives chemotherapy resistance in colorectal cancer. Cell death & disease, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Gynecology nominated in the Fudan list.
-
Breast cancer
Published research
- An integrative multi-omics analysis leveraging Mendelian randomization and subsequent experimental validation prioritizes glutathione S-transferase mu 5 (GSTM5) as a genomic stability-related gene and a therapeutic vulnerability to PLK1 inhibition in breast cancer. International journal of biological macromolecules, 2026
- Individualized dosing strategies in breast cancer chemotherapy: Evidence for therapeutic drug monitoring-guided docetaxel treatment. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2026
8 more published studies
PubMed indexes 10 papers on this condition that name this hospital.
Also ranked: Gynecology nominated in the Fudan list.
-
Liver cancer
Published research
- Correction: RNA‑binding protein CCDC137 activates AKT signaling and promotes hepatocellular carcinoma through a novel non‑canonical role of DGCR8 in mRNA localization. Journal of experimental & clinical cancer research : CR, 2025
- Radiogenomics deciphers tumor heterogeneity in hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma. Discover oncology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Gynecology nominated in the Fudan list.
-
Cervical cancer
Fudan specialty reputation ranking 2023
- Gynecology nominated https://www.fdygs.com/news2023-1.aspx
Published research
- SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2. Communications biology, 2026
- Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cancer. Journal of gynecologic oncology, 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
-
Esophageal cancer
Published research
- Multiomics identifies a cholesterol-TFEB-PLD3-TLR9 axis driving immunosuppressive tumor-associated macrophage polarization in esophageal squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Gynecology nominated in the Fudan list.
-
Ovarian cancer
Fudan specialty reputation ranking 2023
- Gynecology nominated https://www.fdygs.com/news2023-1.aspx
Other hospitals in Shanghai
Source & evidence
- Source URL
- https://www.fdygs.com/news2023-1.aspx
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24